| Year |
Citation |
Score |
| 2016 |
Dhital S, Stokes JV, Park N, Seo KS, Kaplan BL. Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation. Cellular Immunology. PMID 27865421 DOI: 10.1016/J.Cellimm.2016.11.006 |
0.431 |
|
| 2016 |
Phadnis-Moghe A, Chen W, Li J, Crawford RB, Bach T, D'Ingillo S, Kovalova N, Suarez-Martinez JE, Kaplan BL, Harrill JA, Budinsky R, Rowlands JC, Thomas RS, Kaminski NE. Immunological Characterization of the Aryl Hydrocarbon Receptor (AHR) Knockout Rat in the presence and absence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicology. PMID 27590929 DOI: 10.1016/J.Tox.2016.08.019 |
0.677 |
|
| 2016 |
Simkins TJ, Fried D, Parikh K, Galligan JJ, Goudreau JL, Lookingland KJ, Kaplan BL. Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 27287619 DOI: 10.1007/S11481-016-9689-2 |
0.332 |
|
| 2016 |
Yang EJ, Stokes JV, Kummari E, Eells J, Kaplan BL. Immunomodulation by Sub-Chronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26822306 DOI: 10.1093/toxsci/kfw020 |
0.413 |
|
| 2015 |
Szafran B, Borazjani A, Lee JH, Ross MK, Kaplan BL. Lipopolysaccharide Suppresses Carboxylesterase 2g Activity and 2-Arachidonylglycerol Hydrolysis: A Possible Mechanism to Regulate Inflammation. Prostaglandins & Other Lipid Mediators. PMID 26403860 DOI: 10.1016/j.prostaglandins.2015.09.005 |
0.305 |
|
| 2015 |
Kaplan BL, Li J, LaPres JJ, Pruett SB, Karmaus PW. Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology. Toxicological Sciences : An Official Journal of the Society of Toxicology. 145: 214-32. PMID 26008184 DOI: 10.1093/Toxsci/Kfv060 |
0.745 |
|
| 2015 |
Chen W, Crawford RB, Kaplan BL, Kaminski NE. Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ(9)-Tetrahydrocannabinol. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 344-55. PMID 25900076 DOI: 10.1007/S11481-015-9597-X |
0.697 |
|
| 2014 |
Simkins T, Crawford RB, Goudreau JL, Lookingland KJ, Kaplan BL. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 9: 544-57. PMID 24870806 DOI: 10.1007/S11481-014-9549-X |
0.345 |
|
| 2014 |
Chen W, Zhang Q, Kaplan BL, Baker GL, Kaminski NE. Induced T cell cytokine production is enhanced by engineered nanoparticles. Nanotoxicology. 8: 11-23. PMID 24256152 DOI: 10.3109/17435390.2013.848302 |
0.684 |
|
| 2013 |
Ngaotepprutaram T, Kaplan BL, Kaminski NE. Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells. Toxicology and Applied Pharmacology. 273: 209-18. PMID 23999542 DOI: 10.1016/J.Taap.2013.08.023 |
0.802 |
|
| 2013 |
Brandenberger C, Rowley NL, Jackson-Humbles DN, Zhang Q, Bramble LA, Lewandowski RP, Wagner JG, Chen W, Kaplan BL, Kaminski NE, Baker GL, Worden RM, Harkema JR. Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice. Particle and Fibre Toxicology. 10: 26. PMID 23815813 DOI: 10.1186/1743-8977-10-26 |
0.57 |
|
| 2013 |
Ngaotepprutaram T, Kaplan BL, Carney S, Crawford R, Kaminski NE. Suppression by Δ(9)-tetrahydrocannabinol of the primary immunoglobulin M response by human peripheral blood B cells is associated with impaired STAT3 activation. Toxicology. 310: 84-91. PMID 23727458 DOI: 10.1016/J.Tox.2013.05.009 |
0.796 |
|
| 2013 |
Karmaus PW, Wagner JG, Harkema JR, Kaminski NE, Kaplan BL. Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice. Journal of Immunotoxicology. 10: 321-8. PMID 23173851 DOI: 10.3109/1547691X.2012.741628 |
0.772 |
|
| 2013 |
Karmaus PW, Chen W, Crawford R, Kaplan BL, Kaminski NE. Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. Toxicological Sciences : An Official Journal of the Society of Toxicology. 131: 419-33. PMID 23152191 DOI: 10.1093/Toxsci/Kfs315 |
0.822 |
|
| 2012 |
Chen W, Kaplan BL, Pike ST, Topper LA, Lichorobiec NR, Simmons SO, Ramabhadran R, Kaminski NE. Magnitude of stimulation dictates the cannabinoid-mediated differential T cell response to HIVgp120. Journal of Leukocyte Biology. 92: 1093-102. PMID 22899554 DOI: 10.1189/Jlb.0212082 |
0.687 |
|
| 2012 |
Ngaotepprutaram T, Kaplan BL, Crawford RB, Kaminski NE. Differential modulation by delta9-tetrahydrocannabinol (∆9)-THC) of CD40 ligand (CD40L) expression in activated mouse splenic CD4+ T cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 969-80. PMID 22851303 DOI: 10.1007/S11481-012-9390-Z |
0.794 |
|
| 2012 |
Raman P, Kaplan BL, Kaminski NE. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells. The Journal of Pharmacology and Experimental Therapeutics. 342: 816-26. PMID 22700433 DOI: 10.1124/Jpet.112.193003 |
0.692 |
|
| 2012 |
Simkins TJ, Janis KL, McClure AK, Behrouz B, Pappas SS, Lehner A, Kaminski NE, Goudreau JL, Lookingland KJ, Kaplan BL. Comparison of the D2 receptor regulation and neurotoxicant susceptibility of nigrostriatal dopamine neurons in wild-type and CB1/CB2 receptor knockout mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 533-8. PMID 22639229 DOI: 10.1007/S11481-012-9375-Y |
0.485 |
|
| 2012 |
Karmaus PW, Chen W, Kaplan BL, Kaminski NE. Δ9-tetrahydrocannabinol suppresses cytotoxic T lymphocyte function independent of CB1 and CB 2, disrupting early activation events. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 7: 843-55. PMID 21789506 DOI: 10.1007/S11481-011-9293-4 |
0.82 |
|
| 2011 |
Boyd SA, Johnston CT, Pinnavaia TJ, Kaminski NE, Teppen BJ, Li H, Khan B, Crawford RB, Kovalova N, Kim SS, Shao H, Gu C, Kaplan BL. Suppression of humoral immune responses by 2,3,7,8-tetrachlorodibenzo-p-dioxin intercalated in smectite clay. Environmental Toxicology and Chemistry / Setac. 30: 2748-55. PMID 21994089 DOI: 10.1002/Etc.701 |
0.453 |
|
| 2011 |
Karmaus PW, Chen W, Crawford RB, Harkema JR, Kaplan BL, Kaminski NE. Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection. Journal of Leukocyte Biology. 90: 983-95. PMID 21873455 DOI: 10.1189/Jlb.0511219 |
0.824 |
|
| 2011 |
Lu H, Crawford RB, Kaplan BL, Kaminski NE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated disruption of the CD40 ligand-induced activation of primary human B cells. Toxicology and Applied Pharmacology. 255: 251-60. PMID 21807014 DOI: 10.1016/J.Taap.2011.06.026 |
0.728 |
|
| 2011 |
Raman P, Kaplan BL, Thompson JT, Vanden Heuvel JP, Kaminski NE. 15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. Molecular Pharmacology. 80: 201-9. PMID 21511917 DOI: 10.1124/Mol.110.070441 |
0.693 |
|
| 2011 |
Kaplan BL, Crawford RB, Kovalova N, Arencibia A, Kim SS, Pinnavaia TJ, Boyd SA, Teppen BJ, Kaminski NE. TCDD adsorbed on silica as a model for TCDD contaminated soils: Evidence for suppression of humoral immunity in mice. Toxicology. 282: 82-7. PMID 21272611 DOI: 10.1016/J.Tox.2011.01.013 |
0.579 |
|
| 2010 |
Lu H, Crawford RB, Suarez-Martinez JE, Kaplan BL, Kaminski NE. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 118: 86-97. PMID 20702590 DOI: 10.1093/Toxsci/Kfq234 |
0.708 |
|
| 2010 |
Kaplan BL, Lawver JE, Karmaus PW, Ngaotepprutaram T, Birmingham NP, Harkema JR, Kaminski NE. The effects of targeted deletion of cannabinoid receptors CB1 and CB2 on intranasal sensitization and challenge with adjuvant-free ovalbumin. Toxicologic Pathology. 38: 382-92. PMID 20190202 DOI: 10.1177/0192623310362706 |
0.745 |
|
| 2009 |
Lu H, Crawford RB, North CM, Kaplan BL, Kaminski NE. Establishment of an immunoglobulin m antibody-forming cell response model for characterizing immunotoxicity in primary human B cells. Toxicological Sciences : An Official Journal of the Society of Toxicology. 112: 363-73. PMID 19767444 DOI: 10.1093/Toxsci/Kfp224 |
0.798 |
|
| 2009 |
Lu H, Kaplan BL, Ngaotepprutaram T, Kaminski NE. Suppression of T cell costimulator ICOS by Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 85: 322-9. PMID 18988696 DOI: 10.1189/Jlb.0608390 |
0.797 |
|
| 2008 |
Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE. Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol. Journal of Leukocyte Biology. 84: 1574-84. PMID 18791168 DOI: 10.1189/jlb.0508282 |
0.822 |
|
| 2008 |
Kaplan BL, Springs AE, Kaminski NE. The profile of immune modulation by cannabidiol (CBD) involves deregulation of nuclear factor of activated T cells (NFAT). Biochemical Pharmacology. 76: 726-37. PMID 18656454 DOI: 10.1016/j.bcp.2008.06.022 |
0.666 |
|
| 2008 |
Rockwell CE, Raman P, Kaplan BL, Kaminski NE. A COX-2 metabolite of the endogenous cannabinoid, 2-arachidonyl glycerol, mediates suppression of IL-2 secretion in activated Jurkat T cells. Biochemical Pharmacology. 76: 353-61. PMID 18571623 DOI: 10.1016/J.Bcp.2008.05.005 |
0.78 |
|
| 2005 |
Kaplan BL, Ouyang Y, Herring A, Yea SS, Razdan R, Kaminski NE. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide. Toxicology and Applied Pharmacology. 205: 107-15. PMID 15893538 DOI: 10.1016/j.taap.2004.09.013 |
0.547 |
|
| 2005 |
Kaplan BL, Ouyang Y, Rockwell CE, Rao GK, Kaminski NE. 2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2. Journal of Leukocyte Biology. 77: 966-74. PMID 15774549 DOI: 10.1189/Jlb.1104652 |
0.739 |
|
| 2003 |
Kaplan BL, Rockwell CE, Kaminski NE. Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes. The Journal of Pharmacology and Experimental Therapeutics. 306: 1077-85. PMID 12805480 DOI: 10.1124/Jpet.103.051961 |
0.732 |
|
| 2003 |
Kaplan BL, Yu DC, Clay TM, Nishimura MI. Redirecting T lymphocyte specificity using T cell receptor genes. International Reviews of Immunology. 22: 229-53. PMID 12745641 DOI: 10.1080/08830180305227 |
0.346 |
|
| Show low-probability matches. |